Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 325 followers

Latest posts

Last updated about 16 hours ago

Herbal medicinal product: Rusci rhizoma, Ruscus aculeatus L., C: ongoing call for scientific data

about 16 hours ago

Herbal medicinal product: Rusci rhizoma, Ruscus aculeatus L., C: ongoing call for...

Human medicines European public assessment report (EPAR): Evrysdi, risdiplam, Date of authorisation: 26/03/2021, Revision: 15, Status: Authorised

about 16 hours ago

Human medicines European public assessment report (EPAR): Evrysdi, risdiplam, Date of authorisation...

Human medicines European public assessment report (EPAR): Micardis, telmisartan, Date of authorisation: 16/12/1998, Revision: 31, Status: Authorised

about 16 hours ago

Human medicines European public assessment report (EPAR): Micardis, telmisartan, Date of authorisation...

Human medicines European public assessment report (EPAR): Tepmetko, tepotinib, Date of authorisation: 16/02/2022, Revision: 4, Status: Authorised

about 16 hours ago

Human medicines European public assessment report (EPAR): Tepmetko, tepotinib, Date of authorisation...

Summary of opinion: Startvac, 16/04/2026 Positive

about 17 hours ago

Summary of opinion: Startvac, 16/04/2026 Positive

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 April 2026

about 17 hours ago

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 April...

EMA recommends authorisation of first veterinary vaccine using RNA technology

about 17 hours ago

EMA recommends authorisation of first veterinary vaccine using RNA technology

Human medicines European public assessment report (EPAR): Livmarli, maralixibat chloride, Date of authorisation: 09/12/2022, Revision: 10, Status: Authorised

about 22 hours ago

Human medicines European public assessment report (EPAR): Livmarli, maralixibat chloride, Date of...

Human medicines European public assessment report (EPAR): Atriance, nelarabine, Date of authorisation: 22/08/2007, Revision: 30, Status: Authorised

1 day ago

Human medicines European public assessment report (EPAR): Atriance, nelarabine, Date of authorisation...

Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 9, Status: Authorised

1 day ago

Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation...

Recommendations on medication errors

1 day ago

Recommendations on medication errors